Sarda Proteins Board to meet Apr 30 for Q4/FY26 results

Sarda Proteins Ltd has announced that its Board of Directors will convene a meeting on Thursday, April 30, 2026. The primary agenda for this meeting is to consider and approve the standalone Audited financial results for the quarter and financial year ended March 31, 2026. In line with regulatory requirements, the trading window for dealing in the company's securities has been closed from April 1, 2026, and will remain closed until 48 hours after the declaration of these financial results.